TNBC

Open Access
CD84 as a Prognostic Biomarker and Therapeutic Target in Breast Cancer: Interconnections With PDL1, CD74, and Immune Tolerance Mechanisms
UMAR WAZIR, AMBER X. LI, CAROLYN CAI WANG, HENSON HAN GAO, TRACEY A. MARTIN, WEN G. JIANG and KEFAH MOKBEL

Cancer Genomics & Proteomics July 2025, 22 (4) 557-563; DOI: https://doi.org/10.21873/cgp.20521
Open Access
Identification of a Gene Expression Signature to Predict the Risk of Early Recurrence and the Degree of Immune Cell Infiltration in Triple-negative Breast Cancer
KEIKO SATO, KENTARO MIURA, SHOMA TAMORI and KAZUNORI AKIMOTO

Cancer Genomics & Proteomics May 2024, 21 (3) 316-326; DOI: https://doi.org/10.21873/cgp.20450
Open Access
SLFN12 Over-expression Sensitizes Triple Negative Breast Cancer Cells to Chemotherapy Drugs and Radiotherapy
AHMED ADHAM RAAFAT ELSAYED, SARMAD AL-MARSOUMMI, EMILIE E. VOMHOF-DEKREY and MARC D. BASSON

Cancer Genomics & Proteomics May 2022, 19 (3) 328-338; DOI: https://doi.org/10.21873/cgp.20323
Open Access
Prognostic Evaluation of Epidermal Growth Factor Receptor (EGFR) Genotype and Phenotype Parameters in Triple-negative Breast Cancers
SOFIA LEVVA, VASSILIKI KOTOULA, IOANNIS KOSTOPOULOS, KYRIAKI MANOUSOU, CHRISTOS PAPADIMITRIOU, KYRIAKI PAPADOPOULOU, SOTIRIS LAKIS, KYRIAKOS KOUKOULIAS, VASILIOS KARAVASILIS, GEORGE PENTHEROUDAKIS, EUFEMIA BALASSI, FLORA ZAGOURI, IOANNIS G. KAKLAMANOS, DIMITRIOS PECTASIDES, EVANGELIA RAZIS, GERASIMOS ARAVANTINOS, PAVLOS PAPAKOSTAS, DIMITRIOS BAFALOUKOS, GRIGORIOS RALLIS, HELEN GOGAS and GEORGE FOUNTZILAS

Cancer Genomics & Proteomics May 2017, 14 (3) 181-195;

Main menu

User menu

Search

TNBC